SAN DIEGO, CA, November 16, 2011 TandemDiabetes Care, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the Company clearance to market the t:slim™ Insulin Delivery System (t:slim). This new full-featured pump is the first-ever with a color touch screen, and is the
Tandem Diabetes Care Welcomes Bruce W. Bode, MD, FACE, to Clinical Advisory Board SAN DIEGO, CA, August 04, 2010 Tandem Diabetes Care, Inc., a privately-held company, today announced Bruce W. Bode, M.D., FACE, a known advocate for insulin pump therapy, has joined its clinical advisory board. Dr.
Founder of TCOYD, Steve Edelman, M.D. Joins Tandem Diabetes Care Advisory Board SAN DIEGO, CA, June 01, 2010 Tandem Diabetes Care, Inc., a privately-held company, today announced Steven V. Edelman, M.D., has joined the organization as a member of its clinical advisory board. Dr.
Tandem Diabetes Care Appoints Larry A Fox M.D to Clinical Advisory Board SAN DIEGO, CA, April 20, 2009 Tandem Diabetes Care, Inc., a privately-held company, is pleased to announce that Larry A. Fox, M.D., has joined the organization as a member of its clinical advisory board. Dr.
Tandem Diabetes Care Announces Plans for New Corporate Headquarters SAN DIEGO, CA, April 20, 2009 Tandem Diabetes Care, Inc., a privately held company, today announced plans to move and expand its corporate headquarters in San Diego. The Company has signed a lease agreement and is currently
Tandem Diabetes Care Announces Clinical Advisory Board SAN DIEGO, CA, October 13, 2008 Tandem Diabetes Care, Inc., a privately held company, today announced the formation of a clinical advisory board. Committed to advancing the management of diabetes care, Tandem is proud to welcome the following
Kim D. Blickenstaff Joins Tandem Diabetes Care as President & CEO Tandem Diabetes Care, Inc., a privately held company, today announced that Kim D. Blickenstaff has joined the organization as president, chief executive officer and a member of the board of directors.
